• Vaccines

Rabavert Generic Name & Formulations

General Description

Rabies vaccine, inactivated 2.5IU/mL; pwd for IM inj after reconstitution; may contain trace amounts of bovine gelatin, chicken protein, neomycin, chlortetracycline, and amphotericin B.

How Supplied

Single-dose vial—1 (w. diluent)

Rabavert Indications


Preexposure immunization and post-exposure prophylaxis of rabies.

Rabavert Dosage and Administration

Adults and Children

Adults: inject into deltoid area. Small children: inject into thigh. Preexposure immunization: 3 inj of 1mL IM each on day 0, 7, and either day 21 or 28. Booster: 1 dose as needed to maintain antibody titer (see literature). Post-exposure prophylaxis: a 5-dose regimen of 1mL IM given on days 0, 3, 7, 14, and 28 (give 1st dose with human rabies immunoglobulin at a separate site). If previously immunized: 2 inj of 1mL each on days 0 and 3 (no immune globulin needed).

Rabavert Contraindications

Not Applicable

Rabavert Boxed Warnings

Not Applicable

Rabavert Warnings/Precautions


Immunocompromised: may get suboptimal response (monitor titers). Postpone preexposure immunization during acute febrile illness or infection. Egg allergy. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C).

Rabavert Pharmacokinetics

See Literature

Rabavert Interactions


Immunosuppressants: may get suboptimal response.

Rabavert Adverse Reactions

Adverse Reactions

Local reactions, lymphadenopathy, headache, myalgia, malaise, dizziness, neuroparalytic events, anaphylaxis.

Rabavert Clinical Trials

See Literature

Rabavert Note

Not Applicable

Rabavert Patient Counseling

See Literature